We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
What happens on the inside during a myocardial infarction (MI)? We follow the cascade of events.
Once a competitive swimmer, R&D’s Bronwyn Kingwell sees science as a sport of endurance and teamwork.
Understanding the whitish-yellow fat called cholesterol, LDL, HDL and the novel concept of cholesterol efflux.
Yes, it has flavonoids, but you can get those nutrients elsewhere, experts say.
During Heart Month, CSL Behring’s Dr. Danielle Duffy shares what she’s learned as a researcher and practicing cardiologist.
Tab Lassiter – an employee with global vaccines leader Seqirus – endured a six-year battle before receiving a transplant. Eve…
On World Heart Day, CSL Behring reaffirms its commitment to combatting the world’s leading cause of death.
In honor of Heart Month, our cardiovascular experts share why they’re committed to fighting heart disease and improving publi…
About a quarter of patients are hospitalized again within three months, according to new, real-world data shared at the Ameri…
New analysis confirms the threat of recurrent heart attacks still persists.
A research cardiologist at CSL Behring chronicles how the world of science is rolling forward, despite a global pandemic.
The typical patient is changing, but the disease remains world’s leading cause of death.
Popular search terms:
Americas
Asia Pacific
Middle East
Europe
